United Asset Strategies’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,355
| Closed | -$20.8K | – | 247 |
|
|
2022
Q4 | $20.8K | Hold |
1,355
| – | – | ﹤0.01% | 223 |
|
|
2022
Q3 | $8K | Hold |
1,355
| – | – | ﹤0.01% | 209 |
|
|
2022
Q2 | $13K | Hold |
1,355
| – | – | ﹤0.01% | 203 |
|
|
2022
Q1 | $44K | Hold |
1,355
| – | – | 0.01% | 206 |
|
|
2021
Q4 | $65K | Hold |
1,355
| – | – | 0.01% | 205 |
|
|
2021
Q3 | $125K | Hold |
1,355
| – | – | 0.02% | 195 |
|
|
2021
Q2 | $129K | Buy |
+1,355
| New | +$129K | 0.02% | 196 |
|